SNAP23

Synaptosomal-associated protein 23 · O00161 · SNAP23 on Sugi Atlas →

440 patent compounds predicted against SNAP23, 383 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL4699731 SCHEMBL4699731 1.00 2/20
SCHEMBL16111548 SCHEMBL16111548 1.00 2/20
SCHEMBL29358745 SCHEMBL29358745 1.00 2/20
SCHEMBL29380618 SCHEMBL29380618 1.00 2/20
SCHEMBL29931136 SCHEMBL29931136 1.00 2/20
SCHEMBL4697866 SCHEMBL4697866 0.89 2/20
SCHEMBL24532075 SCHEMBL24532075 0.89 2/20
SCHEMBL4697696 SCHEMBL4697696 0.86 2/20
SCHEMBL23092285 SCHEMBL23092285 0.86 2/20
SCHEMBL29688472 SCHEMBL29688472 0.86 2/20
SCHEMBL22024695 SCHEMBL22024695 0.86 2/20
SCHEMBL16136600 SCHEMBL16136600 0.84 2/20
SCHEMBL24532058 SCHEMBL24532058 0.83 2/20
SCHEMBL4699947 SCHEMBL4699947 0.83 2/20
SCHEMBL22025026 SCHEMBL22025026 0.82 2/20
SCHEMBL22119546 SCHEMBL22119546 0.82 2/20
SCHEMBL24532062 SCHEMBL24532062 0.82 2/20
SCHEMBL18804561 SCHEMBL18804561 0.81 2/20
SCHEMBL22024561 SCHEMBL22024561 0.81 2/20
SCHEMBL22025030 SCHEMBL22025030 0.81 2/20

Clinical trials — most relevant to SNAP23 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Ketamine Treatment Effects on Synaptic Plasticity in Depression PHASE4COMPLETED
The Synapse Project PHASE2COMPLETED
A Study to Assess the Safety of BMS-984923 Compared to Placebo, in People With Parkinson's PHASE1UNKNOWN
Changes in Glutamatergic Neurotransmission of Severe TBI Patients EARLY_PHASE1SUSPENDED
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy EARLY_PHASE1ACTIVE_NOT_RECRUITING
Combined Aerobic Exercise and Cognitive Training in Seniors at Increased Risk for Alzheimer's Disease nanNOT_YET_RECRUITING
Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13) nanNOT_YET_RECRUITING
Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices nanACTIVE_NOT_RECRUITING
Study of the Genetic Factors Involved in Autism and Related Disorders nanRECRUITING
Synaptic Injury and Functional Connectivity in Alzheimer's Disease nanCOMPLETED
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort nanRECRUITING
Neurophysiologic Biomarkers in Rett Syndrome nanRECRUITING
Baker Gordon Syndrome Natural History Study nanRECRUITING
miR-142-3p as Potential Biomarker of Synaptopathy in MS nanUNKNOWN
Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome. nanUNKNOWN
Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs. nanENROLLING_BY_INVITATION
Comparing Outcomes of Theta Burst Stimulation in Depression Using Advanced PET Imaging nanNOT_YET_RECRUITING
Efficacy of Probiotics for Parkinson Disease (PD) nanWITHDRAWN
A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES) nanUNKNOWN
STXBP1 and SYNGAP1 Related Disorders Natural History Study nanRECRUITING
Striatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for Precursor Biomarker for Neurodegeneration nanCOMPLETED
Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder nanUNKNOWN
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED
Susceptibility Genes in Autism Spectrum Disorders nanCOMPLETED
Serum Biomarkers in Parkinson's Disease at Different Stages nanRECRUITING
Association of Brain Derived Neurotrophic Factor (BDNF) rs6265 Gene Polymorphism With Susceptibility to Epilepsy nanUNKNOWN
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Familial Aggregation and Biomarkers in REM Sleep Behaviour Disorder. nanUNKNOWN
Sensorimotor Gating in Schizophrenia nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SNAP23 binder may also engage these)

ProteinNameSimilarity
O70377 0.993 O70377 →
P36976 0.990 P36976 →
O09044 0.989 O09044 →
Q0E1I7 0.973 Q0E1I7 →
P36975 0.972 P36975 →
SNAP29 Synaptosomal-associated protein 29 0.970 landscape →
Q9LMG8 0.967 Q9LMG8 →
Q5R5K4 0.966 Q5R5K4 →
Q9SD96 0.966 Q9SD96 →
Q9S7P9 0.965 Q9S7P9 →
Q9ERB0 0.965 Q9ERB0 →
Q9Z2P6 0.965 Q9Z2P6 →
Q6PC54 0.963 Q6PC54 →
P36978 0.960 P36978 →
P58200 0.960 P58200 →
Q0II86 0.958 Q0II86 →
Q9LRP1 0.955 Q9LRP1 →
Q944A9 0.954 Q944A9 →
Q9UEU0 0.953 Q9UEU0 →
Q9SRV7 0.952 Q9SRV7 →
Q2KIU0 0.951 Q2KIU0 →
Q9LNH6 0.951 Q9LNH6 →
P83528 0.950 P83528 →
P83351 0.950 P83351 →
Q7XIE2 0.950 Q7XIE2 →
P61265 0.949 P61265 →
P61266 0.949 P61266 →
Q9ZPV9 0.949 Q9ZPV9 →
P61267 0.949 P61267 →
O70439 0.948 O70439 →